Google DeepMind has released AlphaProteo, an artificial intelligence system focused on generating novel proteins tailored to specific target molecules, aimed at accelerating drug design, disease understanding, and health application research. AlphaProteo successfully designed binders for the protein VEGF-A, which is associated with tumor growth and various disease complications, outperforming traditional methods. Unlike AlphaFold, the proteins designed by this system can interact with biological processes, providing possibilities for developing targeted therapies against harmful proteins.
